4/19
11:23 am
gild
Gilead Sciences, Inc. (NASDAQ: GILD) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $105.00 price target on the stock.
Low
Report
Gilead Sciences, Inc. (NASDAQ: GILD) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $105.00 price target on the stock.
4/19
10:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
4/19
10:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
3/4
08:10 am
gild
Rating for GILD
Low
Report
Rating for GILD
3/4
08:10 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/22
11:25 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/22
11:25 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/14
10:17 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/14
10:17 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/12
12:08 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/12
12:08 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/12
08:37 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/12
08:37 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/7
01:42 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/7
12:07 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/7
12:07 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/7
10:23 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/7
10:23 am
gild
Rating for GILD
Low
Report
Rating for GILD